Gregory Gilot, MD
The FDA approved the use of the reverse shoulder prosthesis in the United States in 2004, nearly 25 years following its re-debut in France. Combined, there are 40 years of experience addressing varying shoulder conditions once treated with non-prosthetic or unconstrained shoulder arthroplasty solutions. Surgical techniques and prosthetic designs have evolved over the years, leading to improvements in clinical outcomes, implant longevity and lower rates of complications. The earliest design, the Grammont-style reverse shoulder arthroplasty (RSA), was built on the engineering premise of a medialized center of rotation, as measured at the center of the glenosphere, in reference to the native glenoid face. While a medialized center of rotation increases the mechanical efficiency of the deltoid, it tends to result in mechanical impingement between the humeral polyethylene insert and the scapula neck. Cadaveric and biomechanical studies as well as computer simulation models have demonstrated the increased risk of the following complications: scapular notching, decreased rotation and prosthetic instability; whereas a lateralized center of rotation has demonstrated superiority in maximizing overall passive arc of motion and preventing scapular notching. In addition, the tensioned soft tissues (remaining rotator cuff and deltoid) effectually improve implant stability.1,2
Surgical lateralization can be achieved via metal or bone. Using a thicker baseplate and/or glenosphere achieves glenoid sided lateralization while increasing joint loading. The increased compressive and shearing forces increases the potential for glenoid loosening.3 To offset the torque forces seen in metallic increase offset (MIO-RSA), bone graft can be placed under the baseplate; and once healed, theoretically, the center of rotation is lateralized and remains at the bone-implant interface.
In a study by Boileau et al, a retrospective case series of 143 shoulders were treated with a BIO-RSA for rotator cuff deficiency.4 It was a multicenter retrospective study with a minimum of five years’ follow-up. All patients in the study had a Grammont-style RSA with the use of autograft harvested from the humerus for bony lateralization. The mean follow-up period was 75 months, the preoperative diagnosis varied, the average age was 72 years, and 72% were women. Patients undergoing revisions or those with insufficient humeral head autograft were excluded. From a technical standpoint, a cylinder of cancellous bone was harvested from the humeral head of 7mm and 10mm thickness, for 42mm sphere and 36mm sphere, respectively, and placed on the baseplate. All baseplates were implanted with a lengthened central peg in 10° of inferior tilt.
Continue reading